ESTRO 2024 - Abstract Book

S5554

RTT - Patient care, preparation, immobilisation and IGRT verification protocols

ESTRO 2024

Keywords: Prehabilitation, Prostate, CT planning preperation

References:

https://prostatecanceruk.org/prostate-information-and-support/risk-and-symptoms/about-prostate cancer#:~:text=Across%20the%20UK,than%2012%2C000%20men%20every%20year . https://www.cancerdata.nhs.uk/radiotherapy/dashboard https://www.macmillan.org.uk/_images/prehabilitation-evidence-and-insight-review_tcm9-335025.pdf Meneses-Echávez, J.F., Loaiza-Betancur, A.F., Díaz-López, V. et al. Prehabilitation programs for cancer patients: a systematic review of randomized controlled trials (protocol). Syst Rev 9, 34 (2020). https://doi.org/10.1186/s13643-020-1282-3 Paterson C, Roberts C, Toohey K, McKie A. Prostate Cancer Prehabilitation and the Importance of Multimodal Interventions for Person-centred Care and Recovery. Semin Oncol Nurs. 2020 Aug;36(4):151048. doi: 10.1016/j.soncn.2020.151048. Epub 2020 Jul 21. PMID: 32709485.

1754

Digital Poster

Prospective randomised comparison of two immobilisation devices for breast cancer patients

Ana Roma, Carine Kirkove, Aude Vaandering, Celine Delvaux, Pascale Henderickx, Michel Derycke, Samira Chelloucki, Claire Toussaint, Raquel Ramos, Christel Abdel Massih, Geneviève Van Ooteghem

Cliniques Universitaires Saint Luc, Radiation Oncology, Brussels, Belgium

Purpose/Objective:

Several devices are available for breast cancer patients positioning, from very simple to more complex systems. In this study, we compared the relevance and ease of use of 2 different devices: (1) MammoRX and (2) AIO Solution (Orfit industries) (Figure 1). We first assessed the interfraction position deviations registered for both devices. Then we evaluated the degree of satisfaction of the radiation therapists (RTTs) using both systems during the trial

Material/Methods:

This was a prospective trial including patients over 18 years old and with a good arm mobilisation treated for breast cancer with and without lymph-nodes. Patients were randomized in 2 arms, according to the positioning device: MammoRX versus (vs) AIO Solution.

During the treatment, patients were positioned based on tattoos, without surface guidance. Patient and target positions were verified on the pre-treatment CBCT (Cone-Beam Computed Tomography). For each patient, 15